Systemic sclerosis
Yannick Allanore, Robert W. Simms, Oliver Distler et al. · Nature Reviews Disease Primers · 2015
Cited by 876 works. doi:10.1038/nrdp.2015.2
Authors
- Yannick Allanore
- Robert W. Simms
- Oliver Distler
- Maria Trojanowska
- Janet Elizabeth Pope
- Christopher P. Denton
- John Varga
References
- Preliminary criteria for the classification of systemic sclerosis (scleroderma)
- Scleroderma (systemic sclerosis): classification, subsets and pathogenesis
- Guidelines for the diagnosis and treatment of pulmonary hypertension
- 2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative
- Continuous Intravenous Epoprostenol for Pulmonary Hypertension Due to the Scleroderma Spectrum of Disease
- 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative
- Cyclophosphamide versus Placebo in Scleroderma Lung Disease
- Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis.
- Changes in causes of death in systemic sclerosis, 1972–2002
- ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension